Withdrawal of AT1 receptor antagonist, TCV-116, affects return of angiotensin I and II responses differentially in hypertensive rats

被引：0
|
作者：
Paull, JRA [1 ]
Widdop, RE [1 ]
机构：
[1] Monash Univ, Dept Pharmacol, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF HYPERTENSION | 1998年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P1553
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [1] Cardiovascular effects of chronic treatment with the AT1 receptor antagonist, TCV-116, in adult spontaneously hypertensive rats
    Paull, JRA
    Widdop, RE
    JOURNAL OF HYPERTENSION, 1998, 16 : S123 - S123
  • [2] HYPOTENSIVE ACTIVITY OF TCV-116, A NEWLY DEVELOPED ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN SPONTANEOUSLY HYPERTENSIVE RATS
    MIZUNO, K
    NIIMURA, S
    TANI, M
    SAITO, I
    SANADA, H
    TAKAHASHI, M
    OKAZAKI, K
    YAMAGUCHI, M
    FUKUCHI, S
    LIFE SCIENCES, 1992, 51 (20) : PL183 - PL187
  • [3] Improvement in baroreflex function of hypertensive rats with myocardial infarction by angiotensin receptor antagonist TCV-116
    Nishizawa, M
    Kumagai, H
    Ichikawa, M
    Suzuki, H
    Saruta, T
    HYPERTENSION, 1996, 28 (03) : P114 - P114
  • [4] Greater inhibition of angiotensin I -: Than angiotensin II -: Induced pressor responses on withdrawal of the AT1 antagonist, TCV-116.
    Widdop, RE
    Paull, JRA
    JOURNAL OF VASCULAR RESEARCH, 1998, 35 : 28 - 28
  • [5] Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT(1)-receptor antagonist, in conscious spontaneously hypertensive rats
    Kanagawa, R
    Wada, T
    Sanada, T
    Ojima, M
    Inada, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 73 (03): : 185 - 190
  • [6] TCV-116 - A NEW ANGIOTENSIN-II TYPE-1 RECEPTOR ANTAGONIST
    MORIMOTO, S
    OGIHARA, T
    CARDIOVASCULAR DRUG REVIEWS, 1994, 12 (02): : 153 - 164
  • [7] The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats
    Y. Nagisa
    A. Shintani
    S. Nakagawa
    Diabetologia, 2001, 44 : 883 - 888
  • [8] The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats
    Nagisa, Y
    Shintani, A
    Nakagawa, S
    DIABETOLOGIA, 2001, 44 (07) : 883 - 888
  • [9] Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats
    Naeshiro, I
    Sato, K
    Chatani, F
    Sato, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (2-3) : 179 - 187
  • [10] TCV-116, an angiotensin II type 1 receptor antagonist, reduces hepatic ischemia-reperfusion injury in rats
    Araya, J
    Tsuruma, T
    Hirata, K
    Yagihashi, A
    Watanabe, N
    TRANSPLANTATION, 2002, 73 (04) : 529 - 534
12345